3159 results for «214»
3159 results
Mastering techniques from basic to complex - TAVI basics
13 Feb 2026 – From PCR Tokyo Valves 2026
This session provides a comprehensive overview of Transcatheter Aortic Valve Implantation (TAVI) fundamentals, emphasizing CT scan analysis for optimal patient and valve selection. It covers strategies to avoid procedural complications and explores streamlined approaches to enhance procedural efficiency.
Mastering mitral TEER: guidelines, complex cases, and Asia Pacific insights
14 Feb 2026 – From PCR Tokyo Valves 2026
This session provides an in-depth analysis of mitral transcatheter edge-to-edge repair (TEER) in light of the 2025 ESC Valvular Heart Disease guidelines. It addresses optimal timing and treatment strategies for severe heart failure beyond established trials, and explores technical solutions for complex anatomies. Special attention is...
All you need to know about redo TAVI
15 Feb 2026 – From PCR Tokyo Valves 2026
This comprehensive session addresses the complexities of redo Transcatheter Aortic Valve Implantation (TAVI). It covers the full spectrum from pre-procedural analysis—including coronary obstruction risk and valve sizing—to procedural strategies like leaflet modification and optimal positioning. Post-procedural management including antithrombotic therapy and patient-prosthesis mismatch are also examined,...
Real world outcomes and strategies for optimal TEER across diverse DMR anatomies
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delves into the real-world complexities of degenerative mitral regurgitation (DMR) and presents advanced strategies for transcatheter edge-to-edge repair (TEER) using the PASCAL device. Participants will explore the latest registry data, device selection criteria, and tactical approaches to manage diverse and challenging DMR anatomies, aiming...
Design that delivers the future of TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses future-oriented TAVI valve design and procedural planning. It highlights supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches to ensure long-term durability and optimal hemodynamics.
Mastering LAA closure: a step-by-step case experience
14 Feb 2026 – From PCR Tokyo Valves 2026
This session presents a step-by-step, case-based approach to mastering left atrial appendage (LAA) closure. It covers pre-procedural planning, device-specific strategies, complication prevention, and complex bailout techniques such as leak closure with coiling or dual-device implantation.
Patient-tailored treatment for bicuspid valve
14 Feb 2026 – From PCR Tokyo Valves 2026
This session focuses on patient-tailored treatment for bicuspid aortic valve stenosis, providing comprehensive insights into the evidence base for TAVI in this population. It discusses critical considerations for valve selection and sizing, and highlights anatomical features that may pose challenges for TAVI procedures. Case studies illustrate...
Mitral TEER masterclass
14 Feb 2026 – From PCR Tokyo Valves 2026
This Mitral TEER masterclass focuses on addressing unique anatomical challenges encountered in Asian populations. The session covers device strategies and techniques tailored for complex anatomies, offering practical tips to minimize complications and improve procedural outcomes through detailed case analyses including small hearts, commissural prolapse with calcification,...
Mastering techniques from basic to complex - Advanced TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
Explore advanced TAVI techniques focusing on challenging patient subsets such as those with small annuli, bicuspid valves, and valve-in-valve procedures. This session reviews valve selection and procedural optimization to enhance clinical outcomes in complex scenarios.
Miscellaneous complications: my worst nightmare
15 Feb 2026 – From PCR Tokyo Valves 2026
Address complications arising from transcatheter interventions in structural heart disease by discussing real-case scenarios and strategies for prevention and management. This session presents challenging cases across TAVI, mitral, and tricuspid interventions to enhance clinical preparedness and patient safety.
Learn from the experts: Evolut first implant technique and treatment strategies
15 Feb 2026 – From PCR Tokyo Valves 2026
This session provides expert insights into evolving clinical practices for aortic valve disease, examining the transcarotid approach as a first alternative. It compares treatment strategies including TAVI, SAV, TAV-in-SAV, and TAVI explantation, with a focus on patient selection, anatomical considerations, and risk-benefit analyses. Additionally, it reviews...
Procedural imaging for tricuspid valve interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
Focused on procedural imaging for tricuspid valve interventions, this session covers essential anatomical and pathophysiological insights necessary for successful transcatheter approaches. It details TEE and ICE imaging techniques including live 3D-MPR, and provides a systematic framework for assessing procedural outcomes and device positioning through interactive case...
From guideline-directed medical therapy to TEER: managing mitral regurgitation and timing transcatheter intervention
15 Feb 2026 – From PCR Tokyo Valves 2026
This session comprehensively addresses the management of secondary mitral regurgitation, differentiating between ventricular and atrial mechanisms. It highlights anatomical evaluation crucial for transcatheter edge-to-edge repair (TEER) candidacy and presents procedural strategies through illustrative cases, underscoring timing and technique considerations for optimal intervention outcomes.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.
Author
Cardiawave announces positive six-month data from valvosoft pivotal study at transcatheter cardiovascular therapeutics (TCT) conference
28 Oct 2024
EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)
03 Nov 2025
Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.
Author
Author
